Hedge fund Situational Awareness, founded by former OpenAI researcher Leopold Aschenbrenner, is investing in data infrastructure and cryptocurrency mining companies, with a focus on fuel cell company Bloom Energy and AI cloud provider CoreWeave.

Odaily News The Ethereum Foundation officially released a reminder update stating that over the past few days, some L2s have noticed that their deployments on Sepolia are not functioning properly. This is due to EIP-7549 changing the proof format. To address the Fusaka incident, all Blob initiators are urged to update their software to create Cell Proof instead of Blob Proof.

Jin10 data reported on September 18 that a hospital in Brasília, the capital of Brazil, announced on the 17th that former President Bolsonaro has been diagnosed with skin cancer. After treatment, his symptoms have improved, and he was discharged that afternoon. Bolsonaro has returned to his residence in Brasília to continue house arrest. According to the hospital announcement, doctors conducted a pathological examination of the excised skin lesions. The report shows that out of the 8 excised skin lesions, two were diagnosed as squamous cell carcinoma in situ. After intravenous infusion treatment, Bolsonaro's related symptoms have improved, but clinical follow-up and regular re-examination are still required.

Jin10 reported on June 24 that Fuhong Hanlin announced that the first patient has been dosed in the Japanese bridge trial of Hanshuang (Sulumab injection) in combination with chemotherapy (carboplatin-etoposide) for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC). This trial aims to support the marketing application of Hanshuang in Japan. Previously, an international multi-center phase 3 clinical trial comparing Hanshuang or placebo in combination with chemotherapy for first-line treatment of ES-SCLC reached its primary endpoint of overall survival (OS) in December 2021.

Gate News bot message, SBF ( Sam Bankman-Fried ), who has been in prison for less than two years, appears in the satirical play "Luigi: The Musical" (. He plays SBF alongside Luigi Mangione ), the alleged murderer of UnitedHealth Group CEO Brian Thompson, and Sean "Diddy" Combs (, who is facing federal trafficking charges. The three characters humorously mock Silicon Valley culture in their prison cell. The play premiered last Friday at the 49-seat Taylor Street Theatre ), setting the story of these three men as cellmates at the Metropolitan Detention Center ( in Brooklyn. Tickets for the San Francisco performance sold out quickly within 24 hours of going on sale.

Jin10 Data reported on April 24th that Tian Ci Materials stated at the performance briefing that the company has conducted research and patent layout on manufacturing methods and upstream raw materials related to PEEK materials, which is currently in the product trial verification stage, with small batch orders already supplied. In addition to its popular applications in the Bots field, PEEK materials also have a broad application space in the chemical industry. Currently, the PEEK products sold by the company are mainly used in modified materials for battery cell structural components.

Jin10 Data, April 12 - Johnson & Johnson announced the official launch of its innovative lung cancer treatment drug, Reco (Evanmato injection), in China. Reco is used in combination with Carboplatin and Pemetrexed for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer confirmed to carry the epidermal growth factor receptor (EGFR) exon 20 insertion mutation.

Jin10 data reported on April 11th, ST Jiuzhi stated at the performance briefing on April 10th that the business of the U.S. cell company invested by the company has not yet been directly affected by the U.S. tariff policy. In addition, the company's business has not yet been directly affected by the U.S. tariff policy.

Jinshi Data News on February 24th, Shenzhou Cell announced that the total operating income for 2024 was 2.513 billion yuan, a rise of 33.13% year-on-year; operating profit was 568 million yuan, a rise of 8829.33% year-on-year; the net profit attributable to the owners of the parent company was 112 million yuan, turning losses into profits year-on-year.